NO2905572T3 - - Google Patents

Info

Publication number
NO2905572T3
NO2905572T3 NO15000230A NO15000230A NO2905572T3 NO 2905572 T3 NO2905572 T3 NO 2905572T3 NO 15000230 A NO15000230 A NO 15000230A NO 15000230 A NO15000230 A NO 15000230A NO 2905572 T3 NO2905572 T3 NO 2905572T3
Authority
NO
Norway
Application number
NO15000230A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2905572T3 publication Critical patent/NO2905572T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C08F226/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/024—Polyamines containing oxygen in the form of ether bonds in the main chain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4083—Concentrating samples by other techniques involving separation of suspended solids sedimentation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4088—Concentrating samples by other techniques involving separation of suspended solids filtration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
NO15000230A 2013-06-05 2015-01-27 NO2905572T3 (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361831445P 2013-06-05 2013-06-05

Publications (1)

Publication Number Publication Date
NO2905572T3 true NO2905572T3 (https=) 2017-12-16

Family

ID=51212941

Family Applications (1)

Application Number Title Priority Date Filing Date
NO15000230A NO2905572T3 (https=) 2013-06-05 2015-01-27

Country Status (26)

Country Link
US (8) US9205107B2 (https=)
EP (4) EP3003327B1 (https=)
JP (5) JP6453860B2 (https=)
KR (5) KR102633597B1 (https=)
CN (3) CN111671767B (https=)
AU (3) AU2014274817B2 (https=)
BR (1) BR112015030142B1 (https=)
CA (1) CA2912911C (https=)
CY (3) CY1119611T1 (https=)
DK (3) DK3003327T3 (https=)
ES (3) ES2733493T3 (https=)
HK (1) HK1251151B (https=)
HR (3) HRP20171590T1 (https=)
HU (3) HUE043999T2 (https=)
IL (3) IL242758B (https=)
LT (3) LT3287133T (https=)
MX (3) MX387845B (https=)
NO (1) NO2905572T3 (https=)
PL (2) PL3287133T3 (https=)
PT (3) PT3003327T (https=)
RS (2) RS59033B1 (https=)
RU (1) RU2728778C2 (https=)
SI (3) SI3003327T1 (https=)
SM (2) SMT202000596T1 (https=)
TR (1) TR201909355T4 (https=)
WO (1) WO2014197725A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3003327B1 (en) 2013-06-05 2017-08-09 Tricida Inc. Proton-binding polymers for oral administration
RS61409B1 (sr) * 2014-12-10 2021-03-31 Tricida Inc Polimeri koji vezuju protone za oralnu primenu opis
CN109414453B (zh) 2016-05-06 2023-02-17 特里赛达公司 用于治疗酸碱失衡的组合物
EP3564292B1 (en) 2016-12-28 2021-06-16 FUJIFILM Corporation Emulsion of nitrogen atom-containing polymer or salt thereof, production method therefor, and production method for particles
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
CN111225674A (zh) 2017-10-16 2020-06-02 富士胶片株式会社 高磷血症治疗剂
AU2018360868B2 (en) * 2017-11-03 2025-01-02 Tricida, Inc. Method of treating acid-base disorders
CA3080651A1 (en) 2017-11-03 2019-05-09 Tricida, Inc. Compositions for and method of treating acid-base disorders
CA3102765A1 (en) * 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
JP2022540707A (ja) * 2019-07-19 2022-09-16 アカテコール・インコーポレイテッド 分子的に十分に規定された生物付着防止ポリイオンコーティング
SI4053179T1 (sl) 2021-03-01 2026-01-30 Renosis, Inc. Farmacevtski sestavki iz premreženega poli(alilaminskega) polimera
IL305604A (en) 2021-03-01 2023-11-01 Tricida Inc Pharmaceutical preparations of cross-linked poly(allylamine) polymer
CN118510524A (zh) * 2021-12-14 2024-08-16 上海石趣医药科技有限公司 氧化银和/或其水合物在制备药物中的用途
CN115260355A (zh) * 2022-05-16 2022-11-01 江苏中天药业有限公司 一种阴离子交换树脂、其制备方法、该树脂与药物的复合物和其掩味制剂
KR20240128205A (ko) 2023-02-17 2024-08-26 주식회사 쓰리디코리아 손잡이가 있는 운동기구용 개인별 맞춤형 그립 제조방법 및 그로써 제조된 개인별 맞춤형 그립
KR102902381B1 (ko) 2023-03-21 2025-12-23 지니에듀테크 주식회사 개인별 맞춤형 그립 형상이 형성된 운동기구용 손잡이
CN117164854B (zh) * 2023-07-07 2026-02-27 中国科学院长春应用化学研究所 一种交联型聚酰亚胺及其制备方法

Family Cites Families (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444221B1 (en) 1992-06-30 2002-09-03 Howard K. Shapiro Methods of treating chronic inflammatory diseases using carbonyl trapping agents
US20050090553A1 (en) 1992-06-30 2005-04-28 Shapiro Howard K. Compositions and method for treatment of chronic inflammatory diseases
CA2202397C (en) 1994-10-17 2002-07-16 Peter W. Stacpoole Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
US5534259A (en) * 1993-07-08 1996-07-09 Liposome Technology, Inc. Polymer compound and coated particle composition
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5648355A (en) 1994-02-09 1997-07-15 Kos Pharmaceutical, Inc. Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
US20020006899A1 (en) 1998-10-06 2002-01-17 Pospisilik Andrew J. Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
US5753706A (en) 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
AUPO758297A0 (en) 1997-06-27 1997-07-24 Rowe, James Baber Control of acidic gut syndrome
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
DE69941447D1 (de) * 1998-01-05 2009-11-05 Univ Washington Erhöhter transport unter benutzung membranzerstörender stoffe
WO1999040990A1 (en) 1998-02-17 1999-08-19 University Of Maryland Anion binding polymers and the use thereof
US6485703B1 (en) 1998-07-31 2002-11-26 The Texas A&M University System Compositions and methods for analyte detection
US6271264B1 (en) 1998-12-01 2001-08-07 Geltex Pharmaceuticals, Inc. Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB9927088D0 (en) 1999-11-17 2000-01-12 Secr Defence Use of poly(diallylamine) polymers
WO2001066607A1 (en) 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same
AU2001241076A1 (en) 2000-03-09 2001-09-17 Hisamitsu Pharmaceutical Co. Inc. Crosslinked anion-exchange resin or salt thereof
US20030091530A1 (en) 2000-03-13 2003-05-15 Takeshi Goto Preventives and/or remedies for hyperphosphatemia
JP2002028737A (ja) 2000-07-07 2002-01-29 Fujitsu Ltd プレス打ち抜き加工方法及びプレス打ち抜き加工装置
DE60212819T2 (de) * 2001-04-18 2006-11-23 Genzyme Corp., Cambridge Salzformarme polyallylamine
WO2002085381A1 (en) 2001-04-18 2002-10-31 Genzyme Corporation Method for treating gout and binding uric acid
CA2478599A1 (en) 2002-03-11 2003-09-18 Novartis Ag Salts of nateglinide
WO2004069866A1 (en) 2003-02-10 2004-08-19 Autogen Research Pty Ltd Therapeutic molecules
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
CN1540136A (zh) * 2003-10-27 2004-10-27 华东理工大学 一种评价微生物驱油能力的方法
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
CA2551528A1 (en) 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
KR20060128972A (ko) 2004-01-29 2006-12-14 각고호우징 게이오기주크 적혈구 기능 수식 물질
US7556799B2 (en) 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US8192758B2 (en) 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
US8282960B2 (en) 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
US7429394B2 (en) 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
US7854924B2 (en) 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
BRPI0509365B8 (pt) 2004-03-30 2021-05-25 Ilypsa Inc composição farmacêutica, kit farmacêutico, e, uso da referida composição
US8399025B2 (en) 2004-06-04 2013-03-19 Board Of Regents, The University Of Texas System Polyamine modified particles
US8501676B2 (en) 2004-07-19 2013-08-06 N.V. Nutricia Preparation for use of aspartate for regulating glucose levels in blood
DE102004035808A1 (de) 2004-07-21 2006-03-16 Kasch, Helmut, Dr. Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen
US8569277B2 (en) 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US20070293429A1 (en) 2004-10-08 2007-12-20 Therapei Pharmaceuticals, Inc. Vasoactive Intestinal Polypeptide Compositions
US20080214440A1 (en) 2004-10-08 2008-09-04 Forbes Medi-Tech (Research), Inc. Vasoactive intestinal polypeptide compositions
JP2008531751A (ja) * 2004-10-13 2008-08-14 イリプサ， インコーポレイテッド 架橋アミンポリマー
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
ITME20040015A1 (it) 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
WO2006078629A2 (en) * 2005-01-18 2006-07-27 Duke University In-situ crosslinkable elastin-like polypeptides for defect filling in cartilaginous tissue repair
US20080200533A1 (en) 2005-07-04 2008-08-21 Ramu Krishnan Drug or Pharmaceutical Compounds and a Preparation Thereof
CA2619591C (en) 2005-08-18 2020-03-24 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
WO2007041569A1 (en) * 2005-09-30 2007-04-12 Ilypsa, Inc. Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
WO2007038801A2 (en) 2005-09-30 2007-04-05 Ilypsa, Inc. Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
BRPI0616603A2 (pt) * 2005-09-30 2012-12-25 Ilypsa Inc mÉtodo para preparar um compàsito de nécleo-envoltàrio, e para a manufatura de um medicamento, composiÇço farmacÊutica, e, uso da mesma
EP1945196A2 (en) 2005-11-08 2008-07-23 Genzyme Corporation Magnesium-containing polymers for hyperphosphatemia
WO2007055044A1 (ja) 2005-11-08 2007-05-18 Ajinomoto Co., Inc. 麻酔覚醒促進剤
ITMI20052461A1 (it) 2005-12-22 2007-06-23 Univ Degli Studi Milano Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
RU2008136081A (ru) 2006-02-14 2010-03-20 Тева Фармасьютикл Индастриес Лтд. (Il) Фармацевтические составы с алифатическими аминными полимерами и способы их производства
EP2016114A2 (en) 2006-05-05 2009-01-21 Genzyme Corporation Amine condensation polymers as phosphate sequestrants
EP2043627A2 (en) 2006-07-05 2009-04-08 Genzyme Corporation Iron(ii)-containing treatments for hyperphosphatemia
CN101541235A (zh) * 2006-07-18 2009-09-23 基酶有限公司 胺类树状物
US20100124542A1 (en) 2006-07-18 2010-05-20 Genzyme Corporation Amine dendrimers
US8391873B2 (en) 2006-07-21 2013-03-05 Qualcomm Incorporated Systems and methods for coordinating supplementary services for voice telephone calls in a centralized fashion
WO2008016729A1 (en) 2006-08-04 2008-02-07 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
EP2068819A4 (en) * 2006-09-01 2011-04-20 Genzyme Corp Dendrimer COMPOSITIONS
CA2749074A1 (en) 2006-09-01 2008-05-29 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
US7868045B2 (en) 2006-09-06 2011-01-11 Sucampo Ag Method for promoting gastrointestinal bicarbonate secretion
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
JP2010519298A (ja) 2007-02-23 2010-06-03 ゲンズイメ コーポレーション アミンポリマー組成物
US20080207766A1 (en) 2007-02-27 2008-08-28 Agi Therapeutics Research Ltd. Methods and compositions for treating at least one upper gastrointestinal symptom
JP2010520285A (ja) 2007-03-08 2010-06-10 ゲンズイメ コーポレーション スルホンポリマー組成物
TWI445540B (zh) 2007-04-20 2014-07-21 Ajinomoto Kk 抗低體溫組成物
US20100166696A1 (en) 2007-04-27 2010-07-01 Dhal Pradeep K Amido-amine dendrimer compositions
US8273384B2 (en) 2007-07-02 2012-09-25 Stephen Ray Wurzberger Process for the preparation of a non-corrosive base solution and methods of using same
KR20100045965A (ko) 2007-07-11 2010-05-04 도레이 카부시키가이샤 가교 폴리알릴아민 또는 그 산부가염 및 그 의약 용도
EP2016947A1 (en) 2007-07-17 2009-01-21 Chemo Ibérica, S.A. Novel one step process for preparing cross-linked poly(allylamine) polymers
WO2009023544A2 (en) 2007-08-10 2009-02-19 Ilypsa, Inc. Dosage unit anion-exchange polymer pharmaceutical compositions
US20090181359A1 (en) * 2007-10-25 2009-07-16 Lou Sheng C Method of performing ultra-sensitive immunoassays
US20090156647A1 (en) 2007-12-12 2009-06-18 Iovate T. & P. Inc. Method for maintaining physiological pH levels during intensive physical exercise
EP2217215A1 (en) 2007-12-14 2010-08-18 Genzyme Corporation Coated pharmaceutical compositions
PA8807201A1 (es) 2007-12-14 2009-07-23 Genzyme Corp Composiciones farmaceuticas
WO2009097127A1 (en) 2008-01-31 2009-08-06 Genzyme Corporation Pharmaceutical compositions
EP2282729A1 (en) 2008-03-11 2011-02-16 Livionex Inc. Methods and compositions for treating inflammation and inflammation-related pathologies
AU2009235024A1 (en) 2008-04-08 2009-10-15 Usv Limited Process for preparation of amine polymer salt
US20110112445A1 (en) 2008-04-11 2011-05-12 GP Investmenti S.r.l Handpiece for Ultrasound Treatments of Human Tissue
WO2009154747A1 (en) 2008-06-20 2009-12-23 Genzyme Corporation Pharmaceutical compositions
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
US20100008988A1 (en) 2008-07-14 2010-01-14 Glenmark Generics, Ltd. Tablet compositions of amine polymers
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
US8337824B2 (en) 2008-08-22 2012-12-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
WO2010022381A1 (en) 2008-08-22 2010-02-25 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
KR20110066952A (ko) 2008-09-25 2011-06-17 비브 나노, 인코포레이티드 중합체 나노입자 및 활성 성분의 제형을 제조하는 방법
US20110268666A1 (en) 2008-09-29 2011-11-03 Yissum Research Development Company of the Research University of Jerusalem, Ltd. Novel gastroretentive delivery system
WO2010059384A1 (en) 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
US20100166861A1 (en) 2008-12-29 2010-07-01 Kelly Noel Lynch Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
EP2389168A2 (en) 2009-01-22 2011-11-30 USV Limited Pharmaceutical compositions comprising phosphate-binding polymer
WO2011059609A2 (en) 2009-10-13 2011-05-19 The Regents Of The University Of Michigan Dendrimer compositions and methods of synthesis
EP2490675B1 (en) 2009-10-22 2019-01-23 Synthon B.V. Pharmaceutical compositions of sevelamer
JP5984675B2 (ja) 2009-12-07 2016-09-06 アイアンウッド ファーマシューティカルズ インコーポレイテッド 胃腸障害の療法
CN105017481B (zh) 2010-02-24 2018-10-02 瑞立普萨公司 用作胆汁酸螯合剂的交联聚乙烯胺、聚烯丙胺和乙烯亚胺
WO2011106548A1 (en) 2010-02-24 2011-09-01 Relypsa, Inc. Amine polymers for use as bile acid sequestrants
CN102858347B (zh) 2010-02-24 2016-11-02 瑞立普萨公司 用作胆汁酸螯合剂的聚咪唑
RU2417782C1 (ru) * 2010-03-03 2011-05-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Белгородская государственная сельскохозяйственная академия" Способ лечения ацидоза рубца
IT1406068B1 (it) 2010-07-22 2014-02-06 Medestea Int Spa Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
AU2011289426A1 (en) * 2010-08-10 2013-02-28 Amgen Inc. Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
KR101238210B1 (ko) 2011-06-30 2013-03-04 엘지전자 주식회사 이동 단말기
US20130137772A1 (en) 2011-11-29 2013-05-30 Raymond J. Bergeron Hydroxypolyamine salts
US20130345303A1 (en) 2012-06-21 2013-12-26 Keryx Biopharmaceuticals, Inc. Use of ferric citrate in the treatment of chronic kidney disease patients
KR20210005314A (ko) 2012-10-08 2021-01-13 리립사, 인크. 고혈압 및 고칼륨혈증을 치료하기 위한 칼륨-결합제
EP3003327B1 (en) * 2013-06-05 2017-08-09 Tricida Inc. Proton-binding polymers for oral administration
EP3747432A1 (en) 2013-11-04 2020-12-09 Keryx Biopharmaceuticals, Inc. Ferric citrate for reducing cardiac failure in chronic kidney disease patients
RS61409B1 (sr) 2014-12-10 2021-03-31 Tricida Inc Polimeri koji vezuju protone za oralnu primenu opis
CN109414453B (zh) 2016-05-06 2023-02-17 特里赛达公司 用于治疗酸碱失衡的组合物
CA3080651A1 (en) 2017-11-03 2019-05-09 Tricida, Inc. Compositions for and method of treating acid-base disorders
AU2018360868B2 (en) 2017-11-03 2025-01-02 Tricida, Inc. Method of treating acid-base disorders
WO2019236639A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
CA3102765A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
WO2019236124A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders

Also Published As

Publication number Publication date
JP2022107004A (ja) 2022-07-20
RU2015155596A3 (https=) 2018-05-10
AU2014274817B2 (en) 2019-05-23
MX2015016527A (es) 2016-07-22
US11197887B2 (en) 2021-12-14
TR201909355T4 (tr) 2019-07-22
PT3578185T (pt) 2020-11-10
MX2021013880A (es) 2022-06-02
PL3287133T3 (pl) 2019-10-31
KR20210131457A (ko) 2021-11-02
HUE034836T2 (en) 2018-03-28
JP2020203917A (ja) 2020-12-24
US20220096534A1 (en) 2022-03-31
PT3287133T (pt) 2019-07-12
IL278183B (en) 2021-09-30
JP7075455B2 (ja) 2022-05-25
MX387845B (es) 2025-03-19
JP7588871B2 (ja) 2024-11-25
SMT202000596T1 (it) 2021-01-05
RU2728778C2 (ru) 2020-07-31
CY1121801T1 (el) 2020-07-31
EP3578185B1 (en) 2020-08-05
EP3812761A1 (en) 2021-04-28
EP3578185A1 (en) 2019-12-11
US10369169B1 (en) 2019-08-06
RS61005B1 (sr) 2020-11-30
CY1119611T1 (el) 2018-04-04
MX364785B (es) 2019-05-07
KR102717667B1 (ko) 2024-10-16
US20150056451A1 (en) 2015-02-26
IL271932B (en) 2020-11-30
US20180280428A1 (en) 2018-10-04
US20190134075A1 (en) 2019-05-09
US20160074430A1 (en) 2016-03-17
US10363268B2 (en) 2019-07-30
JP2025024009A (ja) 2025-02-19
HRP20201767T1 (hr) 2020-12-25
HRP20171590T1 (hr) 2017-12-29
HUE043999T2 (hu) 2019-09-30
IL278183A (en) 2020-11-30
WO2014197725A1 (en) 2014-12-11
CN111671767B (zh) 2024-03-08
CY1123673T1 (el) 2022-03-24
SI3003327T1 (en) 2018-01-31
CN111671767A (zh) 2020-09-18
CN105377270B (zh) 2020-09-04
HRP20191074T1 (hr) 2019-09-20
AU2019275584B2 (en) 2021-10-21
AU2019219800B1 (en) 2019-09-19
DK3003327T3 (en) 2017-10-23
CN111671766A (zh) 2020-09-18
ES2834485T3 (es) 2021-06-17
US9993500B2 (en) 2018-06-12
PT3003327T (pt) 2017-11-09
HK1223288A1 (en) 2017-07-28
JP2019065024A (ja) 2019-04-25
JP6453860B2 (ja) 2019-01-16
JP2016520652A (ja) 2016-07-14
US10391118B2 (en) 2019-08-27
CA2912911A1 (en) 2014-12-11
EP3812761B1 (en) 2025-12-24
AU2014274817A1 (en) 2015-12-24
SI3287133T1 (sl) 2019-09-30
EP3287133B1 (en) 2019-04-17
EP3003327B1 (en) 2017-08-09
IL242758B (en) 2020-01-30
MX2019005300A (es) 2019-08-12
KR20160041855A (ko) 2016-04-18
US9205107B2 (en) 2015-12-08
CA2912911C (en) 2023-10-03
BR112015030142B1 (pt) 2023-03-07
SI3578185T1 (sl) 2021-01-29
US20200206260A1 (en) 2020-07-02
ES2646271T3 (es) 2017-12-13
LT3287133T (lt) 2019-07-10
CN105377270A (zh) 2016-03-02
LT3003327T (lt) 2017-12-27
HK1251151B (en) 2020-04-24
BR112015030142A2 (pt) 2017-07-25
RU2015155596A (ru) 2017-07-18
ES2733493T3 (es) 2019-11-29
KR20240152425A (ko) 2024-10-21
US9925214B2 (en) 2018-03-27
CN111671766B (zh) 2024-03-08
EP3287133A1 (en) 2018-02-28
KR102941408B1 (ko) 2026-03-20
PL3003327T3 (pl) 2018-02-28
KR102633597B1 (ko) 2024-02-06
EP3003327A1 (en) 2016-04-13
RS59033B1 (sr) 2019-08-30
HK1222120A1 (zh) 2017-06-23
DK3578185T3 (da) 2020-11-02
KR20230114326A (ko) 2023-08-01
LT3578185T (lt) 2020-11-25
US20190231812A1 (en) 2019-08-01
IL271932A (en) 2020-02-27
JP6759316B2 (ja) 2020-09-23
DK3287133T3 (da) 2019-07-01
HUE051198T2 (hu) 2021-03-01
KR102318910B1 (ko) 2021-10-29
AU2019275584A1 (en) 2020-01-02
KR20240023672A (ko) 2024-02-22
US20180015121A1 (en) 2018-01-18
SMT201900391T1 (it) 2019-09-09

Similar Documents

Publication Publication Date Title
AP2016009275A0 (https=)
BR112016013516A2 (https=)
BR112015007533A2 (https=)
BR102016010778A2 (https=)
BR112014017733A2 (https=)
BR112014018502A2 (https=)
BR112014017739A2 (https=)
BR112014019326A2 (https=)
BR112014018516A2 (https=)
BR112014018480A2 (https=)
BR112014017855A2 (https=)
BR112014020341A2 (https=)
BR112014017669A2 (https=)
BR112014021878A2 (https=)
BR112016012903A2 (https=)
NO2905572T3 (https=)
BR112014019204A2 (https=)
BR112014018468A2 (https=)
BR112015015948A2 (https=)
BR112015027303A2 (https=)
BR112014017722A2 (https=)
BR112016010767A2 (https=)
BR112014017653A2 (https=)
BR112014018578A2 (https=)
BR112014018483A2 (https=)